Qian, Yue
Hao, Jing
Zhu, Wei
Yang, Yan
Zhang, Zhuan-yun
Zhou, Lu-yang
Gu, Xiao-ping
Ma, Zheng-liang
Sun, Yu-e
Funding for this research was provided by:
Project of Chinese Hospital Reform and Development Institute Nanjing University (NDYG2022004)
National Nature Science Foundation of China (82071229)
Nanjing Special Fund for Health Science and Technology Development (YKK22089)
Nanjing Drum Tower Hospital 2023 Clinical Research Special Fund (2023-LCYJ-PY-07)
New Technology Development Fund of Nanjing Drum Tower Hospital (XJSFZJJ202016)
Article History
Received: 15 March 2024
Accepted: 22 January 2025
First Online: 4 February 2025
Declarations
:
: The study was approved by the Ethics Committee of Nanjing Drum Tower Hospital (No. 2021-563-01, Data: 22 November 2021) and registered on the Chinese Clinical Trial Registry (No. ChiCTR2300078251, Data: 01 December 2023). The trial was conducted in accordance with Good Clinical Practice guidelines and the Helsinki Declaration. This is a retrospective study based on clinical records, therefore we have submitted an application for exemption from patients’ informed consent and received approval from the ethics committee. Nanjing Drum Tower Hospital internal review board approved the study.
: Not applicable.
: The authors declare no competing interests.